Determination of losartan potassium in the presence of hydrochlorothiazide via a combination of magnetic solid phase extraction and fluorometry techniques in urine samples

被引:13
作者
Farnoudian-Habibi, Amir [1 ]
Kangari, Sahar [2 ]
Massoumi, Bakhshali [3 ]
Jaymand, Mehdi [1 ]
机构
[1] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[2] Islamic Azad Univ, Sci & Res Branch, Dept Chem, Tehran, Iran
[3] Payame Noor Univ, Dept Chem, Tehran, Iran
来源
RSC ADVANCES | 2015年 / 5卷 / 124期
关键词
PERFORMANCE LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; SPECTROFLUOROMETRIC DETERMINATION; ACTIVE METABOLITE; HUMAN PLASMA; NANOPARTICLES; HYPERTENSION; ADSORPTION; PRECONCENTRATION; VALSARTAN;
D O I
10.1039/c5ra20117a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A sensitive and highly efficient method for the determination of losartan potassium (LOS) in the presence of hydrochlorothiazide (HCTZ) via a combination of magnetic solid phase extraction (MSPE) and fluorometry techniques is suggested. For this purpose, imidazolium ionic liquid (Imz)-modified Fe3O4@SiO2 nanoparticles (Fe3O4@SiO2-Imz) were utilized as an adsorbent for the MSPE. Fe3O4@SiO2-Imz exhibited excellent extraction performance for LOS, in part due to the anion-exchange groups in the Imz moiety. The experimental parameters, such as sample pH values, the amount of adsorbent, the extraction time, the desorption solvent, and the desorption time, that could affect the extraction performance were examined and optimized. The determination of LOS in the presence of HCTZ in urine samples was carried out using selective and sensitive excitation-emission fluorescence spectroscopy (EEFS), because only LOS exhibited fluorescence emission at 325 nm, while the HCTZ did not exhibit any fluorescence emission. The limit of detection (LOD) for LOS using this technique was 0.12 ng ml(-1).
引用
收藏
页码:102895 / 102903
页数:9
相关论文
共 43 条
  • [1] Enhanced spectrophotometric determination of Losartan potassium based on its physicochemical interaction with cationic surfactant
    Abdel-Fattah, Laila
    Abdel-Aziz, Lobna
    Gaied, Mariam
    [J]. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2015, 136 : 178 - 184
  • [2] Magnetic nanoparticles based dispersive micro-solid-phase extraction as a novel technique for coextraction of acidic and basic drugs from biological fluids and waste water
    Asgharinezhad, Ali Akbar
    Mollazadeh, Narges
    Ebrahimzadeh, Homeira
    Mirbabaei, Fatemeh
    Shekari, Nafiseh
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2014, 1338 : 1 - 8
  • [3] Preconcentration and spectrofluorometric determination of L-tryptophan in the presence of D-tryptophan using a chiral magnetic nanoselector
    Bagheri, Habibollah
    Ahmadi, Mazaher
    Madrakian, Tayyebeh
    Afkhami, Abbas
    [J]. SENSORS AND ACTUATORS B-CHEMICAL, 2015, 221 : 681 - 687
  • [4] Designing and fabrication of new molecularly imprinted polymer-based potentiometric nano-graphene/ionic liquid/carbon paste electrode for the determination of losartan
    Bagheri, Hasan
    Shirzadmehr, Ali
    Rezaei, Mosayeb
    [J]. JOURNAL OF MOLECULAR LIQUIDS, 2015, 212 : 96 - 102
  • [5] Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
    Balesteros, Manoeld R.
    Faria, Adriana F.
    de Oliveira, Marcone A. L.
    [J]. JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2007, 18 (03) : 554 - 558
  • [6] Use of fullerene-, octadecyl-, and triaconthyl silica for solid phase extraction of tryptic peptides obtained from unmodified and in vitro glycated human serum albumin and fibrinogen
    Department of Biochemistry and Medical Chemistry, University of Pécs, Szigeti str. 12, 7624 Pécs, Hungary
    不详
    不详
    不详
    [J]. J. Sep. Sci., 2009, 2 (295-308): : 295 - 308
  • [7] Multivariate optimization and validation of an analytical methodology by RP-HPLC for the determination of losartan potassium in capsules
    Bonfilio, Rudy
    Teixeira Tarley, Cesar Ricardo
    Pereira, Gislaine Ribeiro
    Nunes Salgado, Herida Regina
    de Araujo, Magali Benjamim
    [J]. TALANTA, 2009, 80 (01) : 236 - 241
  • [8] LOSARTAN POTASSIUM LOWERS BLOOD-PRESSURE MEASURED BY AMBULATORY BLOOD-PRESSURE MONITORING
    BYYNY, RL
    [J]. JOURNAL OF HYPERTENSION, 1995, 13 : S29 - S33
  • [9] Experimental design methodologies to optimise the spectrofluorimetric determination of Losartan and Valsartan in human urine
    Cagigal, E
    González, L
    Alonso, RM
    Jiménez, RM
    [J]. TALANTA, 2001, 54 (06) : 1121 - 1133
  • [10] SHATTUCK LECTURE The Hypertension Paradox - More Uncontrolled Disease despite Improved Therapy
    Chobanian, Aram V.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (09) : 878 - 887